A detailed history of Jpmorgan Chase & CO transactions in Exagen Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 35 shares of XGN stock, worth $86. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35
Previous 34 2.94%
Holding current value
$86
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$1.36 - $2.05 $1 - $2
1 Added 2.94%
35 $0
Q1 2024

May 10, 2024

BUY
$1.42 - $2.3 $12 - $20
9 Added 36.0%
34 $0
Q4 2023

Feb 12, 2024

SELL
$1.45 - $2.39 $3,265 - $5,382
-2,252 Reduced 98.9%
25 $0
Q3 2023

Nov 14, 2023

BUY
$2.24 - $2.93 $31 - $41
14 Added 0.62%
2,277 $5,000
Q1 2023

May 11, 2023

SELL
$2.23 - $2.9 $176 - $229
-79 Reduced 3.37%
2,263 $5,000
Q4 2022

Feb 13, 2023

SELL
$2.1 - $3.4 $6,478 - $10,489
-3,085 Reduced 56.85%
2,342 $6,000
Q3 2022

Nov 14, 2022

SELL
$2.69 - $8.68 $6,587 - $21,257
-2,449 Reduced 31.09%
5,427 $15,000
Q2 2022

Aug 11, 2022

SELL
$4.18 - $7.74 $4,276 - $7,918
-1,023 Reduced 11.5%
7,876 $45,000
Q1 2022

May 11, 2022

SELL
$7.12 - $11.06 $87,106 - $135,308
-12,234 Reduced 57.89%
8,899 $72,000
Q4 2021

Feb 10, 2022

BUY
$8.97 - $14.08 $50,205 - $78,805
5,597 Added 36.03%
21,133 $246,000
Q3 2021

Nov 12, 2021

BUY
$10.25 - $15.21 $159,244 - $236,302
15,536 New
15,536 $211,000

Others Institutions Holding XGN

About EXAGEN INC.


  • Ticker XGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,260,400
  • Market Cap $40.2M
  • Description
  • Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...
More about XGN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.